Dual index kit, chromium single cell human TCR amplification kit, chromium GEM-x single cell 3' chip kit V4 and GEM-x universal 3' gene expression V4

Ended Awarded Last action

Contract number
75N92B25F00002
Awardee
Awarding agency
Obligated
$24,928

Award facts

Contract value 100% obligated
$24,928.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a BPA call to 10X Genomics, Inc. valued at $24,928.00 on September 2, 2025, for Dual Index Kit, Chromium Single Cell Human TCR Amplification Kit, Chromium GEM-X Single Cell 3' Chip Kit V4, and GEM-X Universal 3' Gene Expression V4. Work is performed in Pleasanton, California with a completion date of September 1, 2026. The call carries firm fixed pricing and is not set-aside.

Quick answers

Who was awarded contract 75N92B25F00002?

75N92B25F00002 was awarded to 10X Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 2, 2025.

How much is contract 75N92B25F00002 worth?

The government has obligated $24,928 on 75N92B25F00002.

Is contract 75N92B25F00002 an order under another contract?

Yes. 75N92B25F00002 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92B25F00002 competed?

The extent of competition for 75N92B25F00002 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award